SCHOTT Pharma AG & Co. KGaA (XETRA:1SXP) — Market Cap & Net Worth
Market Cap & Net Worth: SCHOTT Pharma AG & Co. KGaA (1SXP)
SCHOTT Pharma AG & Co. KGaA (XETRA:1SXP) has a market capitalization of $2.39 Billion (€2.05 Billion) as of June 18, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #5736 globally and #885 in its home market, demonstrating a -4.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCHOTT Pharma AG & Co. KGaA's stock price €16.70 by its total outstanding shares 150614616 (150.61 Million). Review SCHOTT Pharma AG & Co. KGaA (1SXP) total liabilities to assess the company's total debt and financial obligations.
SCHOTT Pharma AG & Co. KGaA Market Cap History: 2023 to 2026
SCHOTT Pharma AG & Co. KGaA's market capitalization history from 2023 to 2026. Data shows change from $5.89 Billion to $2.94 Billion (-20.51% CAGR).
SCHOTT Pharma AG & Co. KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCHOTT Pharma AG & Co. KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.63x
SCHOTT Pharma AG & Co. KGaA's market cap is 4.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
29.60x
SCHOTT Pharma AG & Co. KGaA's market cap is 29.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $5.89 Billion | $898.60 Million | $151.84 Million | 6.56x | 38.82x |
| 2024 | $4.43 Billion | $957.09 Million | $149.69 Million | 4.63x | 29.60x |
Competitor Companies of 1SXP by Market Capitalization
Companies near SCHOTT Pharma AG & Co. KGaA in the global market cap rankings as of June 18, 2026.
Key companies related to SCHOTT Pharma AG & Co. KGaA by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #164 globally with a market cap of $142.44 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #267 globally with a market cap of $94.60 Billion USD ( €80.92 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #340 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #542 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | Intuitive Surgical Inc | NASDAQ:ISRG | $142.44 Billion | $402.18 |
| #267 | EssilorLuxottica S. A. | PA:EL | $94.60 Billion | €174.75 |
| #340 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €91.50 |
| #542 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
SCHOTT Pharma AG & Co. KGaA Historical Marketcap From 2023 to 2026
Between 2023 and today, SCHOTT Pharma AG & Co. KGaA's market cap moved from $5.89 Billion to $ 2.94 Billion, with a yearly change of -20.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.94 Billion | +10.60% |
| 2025 | €2.66 Billion | -39.98% |
| 2024 | €4.43 Billion | -24.83% |
| 2023 | €5.89 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of SCHOTT Pharma AG & Co. KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.39 Billion USD |
| MoneyControl | $2.39 Billion USD |
| MarketWatch | $2.39 Billion USD |
| marketcap.company | $2.39 Billion USD |
| Reuters | $2.39 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a… Read more